Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster [NA]

View source ↗

Summary

This clinical trial assesses whether venlafaxine can prevent postherpetic neuralgia in patients with acute herpes zoster. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine (Venlafaxine)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Herpes Zoster, Pain | NA | Status: RECRUITING